Randomized, double-blind, multi-center, phase III clinical trial to evaluate the immunogenicity and safety of MG1109 (egg-based pre-pandemic influenza A/H5N1 vaccine) in healthy adults

Randomized, double-blind, multi-center, phase III clinical trial to evaluate the immunogenicity and safety of MG1109 (egg-based pre-pandemic influenza A/H5N1 vaccine) in healthy adults

Considering the pandemic potential of avian influenza A/H5N1, development of an effective and well-tolerated vaccine is an essential part of pandemic preparedness plans. This phase III, randomized, double-blind study was conducted to assess the immunogenicity and safety profile of an alum-adjuvanted...

Full description

Bibliographic Details
Main Authors: Joon Young Song, Min Joo Choi, Ji Yun Noh, Won Suk Choi, Hee Jin Cheong, Seong-Heon Wie, Jin-Soo Lee, Gyu-Jin Woo, Sang Ho Lee, Woo Joo Kim
Format: Article
Language:English
Published: Taylor & Francis Group 2017-05-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
human influenza
h5n1
influenza vaccines
pandemic
Online Access:http://dx.doi.org/10.1080/21645515.2016.1263410

Internet

http://dx.doi.org/10.1080/21645515.2016.1263410

Similar Items